BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,785.00
+100.00 (2.13%)
At close: Dec 5, 2025
-28.58%
Market Cap 23.28B
Revenue (ttm) 21.92B
Net Income (ttm) -5.63B
Shares Out 4.86M
EPS (ttm) -1,157.12
PE Ratio n/a
Forward PE n/a
Dividend 400.00 (8.58%)
Ex-Dividend Date Dec 29, 2025
Volume 7,037
Average Volume 14,532
Open 4,695.00
Previous Close 4,685.00
Day's Range 4,675.00 - 4,815.00
52-Week Range 4,535.00 - 7,620.00
Beta 0.67
RSI 54.39
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.